Neurotoxic amyloid beta oligomeric assemblies recreated in microfluidic platform with interstitial level of slow flow

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Choi, Yoon Jung ^a   Chae, Sukyung ^a   Kim, Jeong Hun ^a   Barald, Kate F ^b   Park, Joong Yull ^c   Lee, Sang Hoon ^a  

^a Korea University   (South Korea)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c Chung Ang University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CASPASE 3; SYNAPSIN;

ANIMAL; APOPTOSIS; ARTICLE; BIOMIMETICS; CELL CULTURE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECT; EQUIPMENT; METABOLISM; METHODOLOGY; MICROFLUIDICS; NERVE CELL; RAT;

AMYLOID; AMYLOID BETA-PEPTIDES; ANIMALS; APOPTOSIS; BIOMIMETICS; CASPASE 3; CELL SURVIVAL; CELLS, CULTURED; MICROFLUIDICS; NEURONS; RATS; SYNAPSINS;

EID: 84902937102     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01921     Document Type: Article

References (33)

1. Probst, A., Langui, D. & Ulrich, J. Alzheimer's disease: a description of the structural lesions. Brain Pathology 1, 229-239 (1991).
2. Brown, M. S., Ye, J., Rawson, R. B. & Goldstein, J. L. Regulated Intramembrane Proteolysis: Review A Control Mechanism Conserved from Bacteria to Humans. Cell 100, 391-398 (2000).
3. Cirrito, J. R. et al. In vivo assessment of brain interstitial fluid with microdialysis reveals plaque-Associated changes in amyloid-b metabolism and half-life. The Journal of neuroscience 23, 8844-8853 (2003).
4. Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (2002).
5. Lorenzo, A. & Yankner, B. Amyloid Fibril Toxicity in Alzheimer's Disease and Diabetesa. Annals of the New York Academy of Sciences 777, 89-95 (1996).
6. Lorenzo, A.& Yankner, B. A. Beta-Amyloid neurotoxicity requires fibril formation and is inhibited by congo red. Proceedings of the National Academy of Sciences 91, 12243 (1994).
7. Zhu, Y. J., LIN, H. & LAL, R. Fresh and nonfibrillar amyloid b protein (1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AbPchannel-mediated cellular toxicity. The FASEB Journal 14, 1244-1254 (2000).
8. Pallitto, M. M., Ghanta, J., Heinzelman, P., Kiessling, L. L. & Murphy, R. M. Recognition sequence design for peptidyl modulators of b-Amyloid aggregation and toxicity. Biochemistry 38, 3570-3578 (1999).
9. Zetterberg, H., Blennow, K. & Hanse, E. Amyloid b and APP as biomarkers for Alzheimer's disease. Experimental gerontology 45, 23-29 (2010).
10. Hartley, D. M. et al. Protofibrillar intermediates of amyloid b-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. The Journal of neuroscience 19, 8876-8884 (1999).
11. Lashuel, H. A., Hartley, D., Petre, B. M., Walz, T. & Lansbury, P. T. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 418, 291-291 (2002).
12. Lambert, M. et al. Diffusible, nonfibrillar ligands derived from Ab1-42 are potent central nervous system neurotoxins. Proceedings of the National Academy of Sciences 95, 6448 (1998).
13. Klein, W. L., Krafft, G. A. & Finch, C. E. Targeting small A [beta] oligomers: the solution to an Alzheimer's disease conundrum? Trends in neurosciences 24, 219-224 (2001).
14. Janus, C. et al. Ab peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979-981 (2000).
15. Klein,W. L. A [beta] toxicity in Alzheimer's disease: globular oligomers (ADDLs) as new vaccine and drug targets. Neurochemistry international 41, 345-352 (2002).
16. Begley, D. J. & Brightman, M. W. Structural and functional aspects of the bloodbrain barrier. Progress in drug research 61, 39-78 (2003).
17. Du Yan, S. et al. RAGE and amyloid-b peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
18. Stepanichev, M. Y., Moiseeva, Y. V., Lazareva, N., Onufriev, M. & Gulyaeva, N. Single intracerebroventricular administration of amyloid-beta (25-35) peptide induces impairment in short-Term rather than long-Term memory in rats. Brain research bulletin 61, 197-205 (2003).
19. Loo, D. T. et al. Apoptosis is induced by beta-Amyloid in cultured central nervous system neurons. Proceedings of the National Academy of Sciences 90, 7951-7955 (1993).
20. Mark, R. J., Pang, Z., Geddes, J. W., Uchida, K. & Mattson, M. P. Amyloid b-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. The Journal of neuroscience 17, 1046-1054 (1997).
21. Abbott, N. J. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochemistry international 45, 545-552 (2004).
22. Park, J. Y. et al. Differentiation of Neural Progenitor Cells in aMicrofluidic Chip-Generated Cytokine Gradient. Stem Cells 27, 2646-2654 (2009).
23. Park, J. Y., Hwang, C. M. & Lee, S. H. Gradient generation by an osmotic pump and the behavior of human mesenchymal stem cells under the fetal bovine serum concentration gradient. Lab Chip 7, 1673-1680 (2007).
24. Schmit, J. D., Ghosh, K. & Dill, K. What Drives Amyloid Molecules To Assemble into Oligomers and Fibrils? Biophysical Journal 100, 450-458 (2011).
25. Lee, J., Culyba, E. K., Powers, E. T. & Kelly, J. W. Amyloid-b forms fibrils by nucleated conformational conversion of oligomers. Nature Chemical Biology 7, 602-609 (2011).
26. Kesslak, J. P., Nalcioglu, O. & Cotman, C. W. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 41, 51-51 (1991).
27. Choi, Y. J., Park, J. & Lee, S.-H. Size-controllable networked neurospheres as a 3D neuronal tissue model for Alzheimer's disease studies. Biomaterials (2013).
28. Ondrejcak, T. et al. Alzheimer's disease amyloid b-protein and synaptic function. Neuromolecular medicine 12, 13-26 (2010).
29. Park, J. Y., Takayama, S. & Lee, S.-H. Regulating microenvironmental stimuli for stem cells and cancer cells using microsystems. Integrative Biology 2, 229-240 (2010).
30. Schenk, D. et al. Immunization with amyloid-bold beta attenuates Alzheimerdisease-like pathology in the PDAPP mouse. Nature 400, 173-177 (1999).
31. Morgan, D. et al. Ab peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982-985 (2000).
32. Nicoll, J. A. R. et al. Neuropathology of human Alzheimer disease after immunization with amyloid-b peptide: a case report. Nature medicine 9, 448-452 (2003).
33. Klein, W. L., Krafft, G. A. & Finch, C. E. Targeting small Ab oligomers: the solution to an Alzheimer's disease conundrum? Trends in neurosciences 24, 219-224 (2001).